Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue
+34.1%
EPS
+34.4%
Free cash flow
−85.8%
Total debt
−0.06%

Quarter to September 2026, against a year earlier

313.12 50.64 −13.92%
Market cap
$52.4B
P/E
0.0×
Fwd P/E
−289×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
20.47 14.37 11.32 13.58
P/FCF ratio
1,134.89 461.93 270.78 287.05
P/Operating CF
1,355.41 709.82 704.46 423.90
P/B ratio
31.85 21.35 15.95 18.29
EV/Sales
20.22 14.10 11.03 13.27
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
1,121.08 453.32 263.88 280.55
Current Ratio
2.81 3.00 2.96 3.39
Net Debt/EBITDA
0.00 18.52 13.75 114.60
Debt/Equity
0.04 0.04 0.05 0.05
Earnings Yield
(0.28%) (0.50%) (0.82%) (0.67%)
Free Cash Flow Yield
0.09% 0.22% 0.37% 0.35%
Free Cash Flow per Share
0.04 (0.06) 0.13 0.28
Book value per Share
12.98 12.71 12.54 12.52
Free Cash Flow
5.25 (8.64) 18.03 37.82
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026